Hahn, Robert G; Wüthrich, Patrick Yves; Zdolsek, Joachim H (2021). Can perioperative hemodilution be monitored with non-invasive measurement of blood hemoglobin? BMC anesthesiology, 21(1), p. 138. BioMed Central 10.1186/s12871-021-01351-4
|
Text
Can_perioperative_hemodilution_Wuethrich_BMC_Anesthesiology_2021.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
BACKGROUND
Trends in non-invasive measurements of blood hemoglobin (Hb) may be useful for identifying the need for transfusion in the perioperative period.
METHODS
Crystalloid fluid (5-20 mL/kg) was administered intravenously or by mouth to 30 volunteers and 33 surgical patients in five non-randomized clinical studies where Hb was measured on 915 occasions by non-invasive (Radical-7™) and invasive methodology. The hemodilution curves were compared by volume kinetic analysis and linear regression, with the slope and scattering of the data as key outcome measures.
RESULTS
The slope was 1.0, indicating unity between the two modes of measuring Hb when crystalloid fluid was infused in volunteers; however, only 40-45% of the variability in the non-invasive Hb could be explained by the invasive Hb. Patients undergoing major surgery, who showed the most pronounced hemodilution (median 24 g/L); non-invasive Hb explained 72% of the variability but indicated only half the magnitude of the invasive Hb changes (slope 0.48, P < 0.001 versus the volunteers). Simulations based on volume kinetic parameters from the volunteers showed 25% less plasma volume expansion after infusion when based on non-invasive as compared to invasive Hb, while no difference was found during infusion.
CONCLUSIONS
In volunteers the non-invasive Hb had good accuracy (low bias) but poor precision. In surgical patients the non-invasive Hb had good precision but systematically underestimated the hemodilution. Despite severe limitations, the non-invasive technology can be used to follow Hb trends during surgery if supported by occasional invasive measurements to assure acceptable quality of the hemodilution curve.
TRIAL REGISTRATIONS
ControlledTrials.gov NCT01195025, NCT01062776, NCT01458678, NCT03848507, and NCT01360333 on September 3, 2010, February 4, 2010, October 25, 2011, February 20, 2019, and May 25, 2011, respectively.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic and Policlinic for Anaesthesiology and Pain Therapy |
UniBE Contributor: |
Wüthrich, Patrick Yves |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1471-2253 |
Publisher: |
BioMed Central |
Language: |
English |
Submitter: |
Jeannie Wurz |
Date Deposited: |
28 Jun 2021 13:49 |
Last Modified: |
05 Dec 2022 15:51 |
Publisher DOI: |
10.1186/s12871-021-01351-4 |
PubMed ID: |
33957864 |
Uncontrolled Keywords: |
Hemoglobin Non-invasive measurement Point of care tests Pulse oximetry |
BORIS DOI: |
10.48350/156688 |
URI: |
https://boris.unibe.ch/id/eprint/156688 |